Ainos, Inc. Stock

AIMD

US00902F4028

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 06:00:00 17/06/26 am AEST			5-day change	1st Jan Change
1.880 ^USD	+2.17%		-7.84%	+14.63%

27/05	Top Premarket Decliners	MT
14/05	Ainos, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

on all subscriptions*

Last hours

Enjoy this offer

* See conditions under "Our services"

Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogrenâ€™s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
16/06/26	1.880 $	+2.17%	44,157
15/06/26	1.840 $	-3.66%	56,958
12/06/26	1.910 $	-0.52%	25,852
11/06/26	1.920 $	+1.59%	50,516
10/06/26	1.890 $	-7.35%	27,101

Delayed Quote Nasdaq

More quotes

Income Statement and Estimates

More financial data

Market Cap	13.85M 11.93M 10.99M 10.32M 19.37M 1.31B 19.57M 130M 50.58M 641M 51.96M 50.86M 2.22B	P/E Ratio 2024	-0.29x	P/E Ratio 2025	-0.47x
Enterprise Value	24.43M 21.05M 19.39M 18.2M 34.17M 2.31B 34.53M 229M 89.24M 1.13B 91.68M 89.73M 3.92B	EV / Sales 2024	701x	EV / Sales 2025	162x
Free-Float	33.62%	Yield 2024 *	-	Yield 2025	-

27/05	Top Premarket Decliners	MT
14/05	Ainos, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
31/03	Ainos, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
30/03	Ainos, Inc. Auditor Raises 'Going Concern' Doubt	CI
07/01	Ainos on Dec 30 2025, enters distribution agreement with Trusval Technology	RE
07/01	Ainos, Inc. Enters into a Distribution Agreement with Trusval Technology Co. Ltd	CI
14/11	Ainos, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Ainos, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
07/08/25	Ainos, Inc. Secures $2.1 Million Order with ASE Technology Holding Co., Ltd	CI
27/06/25	Ainos, ASE Technology to Expand AI Nose Technology in Semiconductor Facility	MT
27/06/25	Ainos Plans 1-for-5 Reverse Stock Split	MT
24/06/25	Ainos, Inc. and Kenmec Mechanical Engineering Co., Ltd. Launch Strategic Partnership to Deploy Ai-Powered Scent Intelligence in Smart Factories Across Asia	CI
15/05/25	Ainos, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI

08/06	Ainos Releases 2026 Mid-Year CEO Letter to Shareholders	AQ
05/06	VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations	AQ
04/06	RedChip Showcases Public Companies Driving Technological Innovation at June 10 Virtual Investor Conference	AQ
03/06	Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study	AQ
01/06	Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis	AQ

1 day	+2.17%
1 week	-7.84%
Current month	-21.01%
1 month	+10.59%
3 months	+31.47%
6 months	-12.56%
Current year	+14.63%

1 week	1.82	2.01
1 month	1.45	3.88
Current year	1.26	3.88
1 year	1.26	4.5
3 years	1.26	30.5
5 years	1.26	645
10 years	1.26	1,781.25

Ainos, Inc. Stock

Stocks

AIMD

US00902F4028

Advanced Medical Equipment & Technology

Valuation: Ainos, Inc.

Chart: Ainos, Inc.

Latest news : Ainos, Inc.

Press Releases: Ainos, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Ainos, Inc.

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Manager	Title	Age	Since
Chun Hsien Tsai CEO	Chief Executive Officer	56	15/04/2021
Christopher Lee DFI	Director of Finance/CFO	54	15/03/2024

Director	Title	Age	Since
Chung Yi Tsai BRD	Director/Board Member	49	15/04/2021
Chung Jung Tsai BRD	Director/Board Member	54	15/04/2021
Ting Chuan Lee BRD	Director/Board Member	42	15/04/2021

Date	Insider	Type	Main position	Quantity	% Market Cap.
05/06	Yao Chung Chiang	Buy	Director	3,500	0.0501%
03/06	Yao Chung Chiang	Buy	Director	2,000	0.0286%
28/05	Yao Chung Chiang	Buy	Director	250	0.0036%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AINOS, INC.	+2.17%	-7.84%	-25.34%	-89.82%	13.85M
THERMO FISHER SCIENTIFIC, INC.	-0.23%	-4.34%	+16.68%	-12.04%	176B
INTUITIVE SURGICAL, INC.	+0.12%	-2.24%	-19.65%	+26.63%	148B
DANAHER CORPORATION	+0.14%	-3.75%	-9.83%	-25.00%	128B
BOSTON SCIENTIFIC CORPORATION	+0.34%	-4.17%	-53.77%	-13.62%	69.74B
EDWARDS LIFESCIENCES CORPORATION	+2.67%	+1.19%	+18.39%	-3.65%	51B
SIEMENS HEALTHINEERS AG	+0.97%	+0.60%	-23.33%	-33.14%	45.7B
AGILENT TECHNOLOGIES, INC.	-1.72%	-5.27%	+7.83%	+5.95%	36.25B
WATERS CORPORATION	+0.78%	-2.86%	+3.66%	+33.93%	35.4B
GE HEALTHCARE TECHNOLOGIES INC.	-2.36%	-4.21%	-13.22%	-19.61%	28.76B
Average	+0.16%	-2.92%	-9.86%	-13.04%	71.86B
Weighted average by Cap.	+0.05%	-2.86%	-7.07%	-4.44%

	2024	2025
Net sales	20.73K 17.86K 16.45K 15.45K 29K 1.96M 29.3K 194K 75.73K 960K 77.79K 76.14K 3.33M	124K 107K 98.53K 92.51K 174K 11.74M 176K 1.16M 454K 5.75M 466K 456K 19.92M
Net income	-14.86M -12.81M -11.8M -11.07M -20.79M -1.41B -21.01M -139M -54.3M -688M -55.78M -54.6M -2.38B	-14.77M -12.73M -11.72M -11.01M -20.66M -1.4B -20.88M -139M -53.96M -684M -55.43M -54.26M -2.37B
Net Debt	8.11M 6.99M 6.43M 6.04M 11.34M 766M 11.46M 76.02M 29.62M 375M 30.43M 29.78M 1.3B	10.58M 9.12M 8.4M 7.89M 14.8M 1B 14.96M 99.24M 38.66M 490M 39.72M 38.87M 1.7B